← Back to Search

Behavioral Intervention

ERRT for Bipolar Disorder (BERRT Trial)

N/A
Recruiting
Led By Joanne L Davis, PhD
Research Sponsored by University of Tulsa
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Formal diagnosis of Bipolar disorder (I or II)
Nightmares at least once per week for the past month
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre, one week, three months
Awards & highlights

Summary

This trial will assess whether exposure, relaxation, and rescripting therapy (ERRT) is effective in reducing nightmares and improving sleep quality in individuals diagnosed with bipolar disorder.

Who is the study for?
This trial is for adults with Bipolar Disorder (I or II) who have experienced a traumatic event over a month ago and suffer from frequent nightmares. Participants must be stable on bipolar medication for at least two months and not currently experiencing mania/hypomania, recent suicide attempts, hospitalizations, or untreated substance use disorders.Check my eligibility
What is being tested?
The study tests ERRT-Bipolar Disorder, a therapy aimed at reducing trauma-related nightmares and improving sleep in those with bipolar disorder. The effectiveness of this psychological intervention will be evaluated by its impact on the frequency and intensity of nightmares.See study design
What are the potential side effects?
While specific side effects are not detailed here, psychological interventions like ERRT may sometimes lead to temporary increases in distress due to confronting traumatic memories during treatment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with Bipolar disorder.
Select...
I have experienced nightmares at least once a week for the last month.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre, one week, three months
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre, one week, three months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Past Week Nightmare Frequency
Secondary outcome measures
Change in Clinician Administered PTSD Scale Symptoms

Trial Design

1Treatment groups
Experimental Treatment
Group I: Nightmare TreatmentExperimental Treatment1 Intervention
The nightmare treatment, Exposure, Relaxation, and Rescripting Therapy for Bipolar disorder (ERRT-Bipolar Disorder), is a weekly 5-session treatment aimed at reducing chronic trauma nightmares and sleep disturbances in adults diagnosed with bipolar disorder.

Find a Location

Who is running the clinical trial?

University of TulsaLead Sponsor
15 Previous Clinical Trials
10,805 Total Patients Enrolled
5 Trials studying Nightmares
275 Patients Enrolled for Nightmares
Joanne L Davis, PhDPrincipal InvestigatorUniversity of Tulsa
1 Previous Clinical Trials
50 Total Patients Enrolled

Media Library

ERRT-Bipolar Disorder (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT02242110 — N/A
Nightmares Research Study Groups: Nightmare Treatment
Nightmares Clinical Trial 2023: ERRT-Bipolar Disorder Highlights & Side Effects. Trial Name: NCT02242110 — N/A
ERRT-Bipolar Disorder (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02242110 — N/A
Nightmares Patient Testimony for trial: Trial Name: NCT02242110 — N/A
~4 spots leftby May 2027